Licensed Cannabis Dispensaries (Thai Medical Tier)
Licensed cannabis dispensaries in Thailand emerged rapidly after cannabis was removed from Category 5 narcotics in June 2022 under the Narcotics Act amendment. At peak in 2023, over 6,000 shops registered with the Thai FDA. Following the 2024 government shift and moves toward recriminalisation of recreational use, the market contracted significantly, leaving a medically oriented licensed-dispensary tier operating under Thai FDA dispensary licences. These operators provide cannabis flower, extracts, and products to patients with physician consultations, predominantly in Bangkok, Chiang Mai, and tourist destinations. The surviving dispensary network represents the regulated medical-cannabis retail layer relevant to pharmaceutical, wellness, and tourism market analysis. Operators face ongoing regulatory uncertainty ahead of the Cannabis-Hemp Act passage.
Snapshot
Headline numbers a buyer checks first.
Peak registered dispensaries
~6,000–18,000
2022-2023
Estimates vary by source; Thai FDA registered figure vs. active operations differ significantly
Surviving compliant operators (est.)
1,500–2,500
2024-2025
Approximately 15% of peak cohort with valid Thai FDA dispensary licences and practitioner affiliations
Key geographic clusters
Bangkok, Chiang Mai, Phuket, Pattaya
2025
Regulatory status
Thai FDA dispensary licence, practitioner affiliation required
Ongoing
Profile overview
Licensed cannabis dispensaries in Thailand emerged rapidly after cannabis was removed from Category 5 narcotics in June 2022 under the Narcotics Act amendment. At peak in 2023, over 6,000 shops registered with the Thai FDA. Following the 2024 government shift and moves toward recriminalisation of recreational use, the market contracted significantly, leaving a medically oriented licensed-dispensary tier operating under Thai FDA dispensary licences. These operators provide cannabis flower, extracts, and products to patients with physician consultations, predominantly in Bangkok, Chiang Mai, and tourist destinations. The surviving dispensary network represents the regulated medical-cannabis retail layer relevant to pharmaceutical, wellness, and tourism market analysis. Operators face ongoing regulatory uncertainty ahead of the Cannabis-Hemp Act passage.
Dispensary segment overview
Medical dispensaries
Thai FDA licensed medical tier
Approximately 1,500-2,500 dispensaries hold valid Thai FDA licences with affiliated licensed practitioners. These operators focus on THC:CBD oil ratios, CBN sleep products, and topical preparations for patients seeking cannabis-based treatment under physician consultation.
Hospital tier
Licensed hospital pharmacy dispensing
BDMS, Bumrungrad, and other licensed hospital networks maintain in-house pharmacy cannabis dispensing largely unaffected by the dispensary market turbulence. Hospital-based dispensing is the most compliant tier and represents the model the Cannabis-Hemp Act may seek to expand.
Wellness pivot
CBD and hemp product expansion
Surviving dispensaries have shifted product mix toward CBD cosmetics, hemp food products, and wellness offerings that carry lower regulatory risk than high-THC flower. This pivot repositions dispensaries closer to health-retail than pharmacy, reducing scrutiny while sustaining revenue.
Tourist-zone tier
Designated-zone scenario operators
The draft Cannabis-Hemp Act's wellness-zone scenario could allow 300-500 additional regulated dispensaries in designated tourist areas. Operators preparing for this tier are investing in compliance documentation, practitioner-affiliation arrangements, and English-language patient-education materials.
Thai cannabis dispensary market: evolution 2022–2025
Jun 2022 (decrim day)
Registered dispensaries (est.)
Near-zero
Regulatory environment
Narcotics Act amendment passed
Market character
Pre-market
Late 2022
Registered dispensaries (est.)
~1,000–2,000
Regulatory environment
Thai FDA licensing opens
Market character
Rapid ramp
Mid-2023 (peak)
Registered dispensaries (est.)
6,000–18,000
Regulatory environment
Grey-zone; enforcement low
Market character
Recreational-adjacent boom
Late 2023–2024
Registered dispensaries (est.)
Contracting
Regulatory environment
Pheu Thai recrim signals
Market character
Mass exit; compliance retreat
2025 (current)
Registered dispensaries (est.)
~1,500–2,500 compliant
Regulatory environment
Draft Act pending; Thai FDA enforcement
Market character
Medical-tier consolidation
| Period | Registered dispensaries (est.) | Regulatory environment | Market character |
|---|---|---|---|
| Jun 2022 (decrim day) | Near-zero | Narcotics Act amendment passed | Pre-market |
| Late 2022 | ~1,000–2,000 | Thai FDA licensing opens | Rapid ramp |
| Mid-2023 (peak) | 6,000–18,000 | Grey-zone; enforcement low | Recreational-adjacent boom |
| Late 2023–2024 | Contracting | Pheu Thai recrim signals | Mass exit; compliance retreat |
| 2025 (current) | ~1,500–2,500 compliant | Draft Act pending; Thai FDA enforcement | Medical-tier consolidation |
Watchpoints 2025-2026
Legislation
Cannabis-Hemp Act passage timeline
The draft Cannabis-Hemp Act is the existential variable for the dispensary sector. A strict medical-only outcome grandfathers approximately 1,000-2,000 compliant operators under physician oversight; a tourist-zone scenario permits 300-500 additional wellness dispensaries. The Act's final form determines which operators survive and at what compliance cost.
Enforcement
Thai FDA inspection and licence renewal
Thai FDA is increasing inspection frequency for dispensaries, with a focus on practitioner-affiliation documentation, product labelling, and THC content compliance. Operators without a licensed physician or TTM practitioner on staff are at high risk of non-renewal when their dispensary licence expires.
Hospital competition
BDMS and Bumrungrad medical cannabis
Licensed hospital pharmacy dispensing by BDMS and Bumrungrad represents the premium-compliant tier that a tighter regulatory framework would favour. As the Act progresses, hospital-affiliated dispensing may capture the most commercially viable medical-cannabis patient segments, reducing addressable market for standalone dispensaries.
Related Market profiles
Peers, parents, partners, agencies, and other Cannabis & Hemp actors.
Competitor
Thai Cannabis-Licensed Medical Practitioners
Thai physicians and traditional medicine practitioners licensed by the Medical Council to prescribe cannabis-derived treatments under the post-2022 regulatory framework.
Open Market profile →
Competitor
GACP-Certified Cannabis Cultivators (Thailand)
Thai agricultural operators certified under Good Agricultural and Collection Practices (GACP) for cannabis cultivation; prerequisite for medical-grade and export-quality cannabis supply.
Open Market profile →
Reports featuring this profile
Thailand Cannabis & Hemp Industry Market Intelligence
Atomised retail tier under new prescription regime; most informal
Open report →
Sits alongside 3 other Atlas profilesThai Cannabis: Decriminalisation Rollback and the Medical-Tier Future
Approximately 15.5% of original 18,433 cohort that successfully renewed licenses under stricter rules.
Open report →
Sits alongside 5 other Atlas profilesRelated Market profiles
competitor
Thai Cannabis-Licensed Medical Practitioners
Thai physicians and traditional medicine practitioners licensed by the Medical Council to prescribe cannabis-derived treatments under the post-2022 regulatory framework.
competitor
GACP-Certified Cannabis Cultivators (Thailand)
Thai agricultural operators certified under Good Agricultural and Collection Practices (GACP) for cannabis cultivation; prerequisite for medical-grade and export-quality cannabis supply.